Found: 3
Select item for more details and to access through your institution.
Six Months of Recombinant Human GH Therapy in Patients with Ischemic Cardiac Failure Does Not Influence Left Ventricular Function and Mass.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 10, p. 4638, doi. 10.1210/jcem.86.10.7832
- By:
- Publication type:
- Article
Additional Beneficial Effects of Alendronate in Growth Hormone (GH)-Deficient Adults with Osteoporosis Receiving Long-Term Recombinant Human GH Replacement Therapy: A Randomized Controlled Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 6, p. 3079, doi. 10.1210/jcem.86.7.7669
- By:
- Publication type:
- Article
A Switch from Oral (2 mg/Day) to Transdermal (50 μg/Day) 17β-Estradiol Therapy Increases Serum Insulin-Like Growth Factor-I Levels in Recombinant Human Growth Hormone (GH)-Substituted Women with GH Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 1, p. 464, doi. 10.1210/jcem.85.1.6311
- By:
- Publication type:
- Article